GOSSAMER BIO, INC. (GOSS) ROI
- 2024-12-31: ROI -191.67%.
- 2024-09-30: ROI -132.35%.
- 2024-06-30: ROI -99.17%.
- 2024-03-31: ROI -475.28%.
Complete source-backed roi history.
- Available history
- 2021-12-31 to 2024-12-31
- Data captured
Historical ROI
| Date | ROI |
|---|
| 2024-12-31 | -191.67% |
|---|
| 2024-09-30 | -132.35% |
|---|
| 2024-06-30 | -99.17% |
|---|
| 2024-03-31 | -475.28% |
|---|
| 2023-12-31 | -239.13% |
|---|
| 2023-09-30 | -156.37% |
|---|
| 2023-06-30 | 462.09% |
|---|
| 2023-03-31 | 2896.33% |
|---|
| 2022-12-31 | -642.91% |
|---|
| 2021-12-31 | -155.44% |
|---|
Annual ROI
| Date | ROI |
|---|
| 2024-12-31 | -191.67% |
|---|
| 2023-12-31 | -239.13% |
|---|
| 2022-12-31 | -642.91% |
|---|
| 2021-12-31 | -155.44% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|